The glucose-regulated protein (GRP) system in mammalian cells is induced by glucose deprivation, anoxia, the calcium ionophore A23187, and 2-deoxyglucose. In Chinese hamster ovary cells the major 97, and 170 kDa.
and/or nutrient deprivation can occur during tumor development, a GRP-induced state in the tumor may confer resistance to doxorubicin treatment.
Glucose deprivation results in the induction of a set of proteins that are referred to as glucose-regulated proteins (GRPs; ref. 1 and see review in ref. 2) . In addition to glucose deprivation, this system can be induced by 2-deoxyglucose (3) , the calcium ionophore A23187 (4), chronic anoxia (5) , and viral infection (6) . The GRP system represents a subset of a group of stress proteins that also includes the major heat shock proteins. In the case of the heat shock proteins, it has been shown that the application of a heat shock proteininducing stress results in concomitant expression of a heatresistant state referred to as thermotolerance (7) (8) (9) (10) (11) . GRPs, however, are not associated with thermotolerance (12) .
Independent of these studies, it is also recognized that two conditions that induce GRPs, chronic anoxia and 2-deoxyglucose, lead to resistance to the drug doxorubicin (13) (14) (15) (16) . Based on these studies we consider here the hypothesis that GRP induction confers resistance to this chemotherapeutic agent in analogy to studies relating heat shock proteins and heat resistance. To test this hypothesis, we first used glucose deprivation, the most common method of GRP induction. We report that this treatment as well as A23187 induce resistance to doxorubicin. Finally, with all four inducers, there is a good temporal correlation between the application of the GRP-inducing stress and the induction of cellular resistance to doxorubicin and between the removal of the GRP-inducing stress and repression of cellular resistance to doxorubicin.
The development of drug resistance is a major limiting factor in determining the success of cancer chemotherapy, and the investigation of mechanisms of resistance has attracted considerable attention (17) (18) (19) . Since hypoxia and nutrient deprivation can occur during tumor development, this information suggests an alternative approach to the study of the mechanism(s) by which resistance to this chemotherapeutic agent may occur and connects this protective phenomenon with conditions associated with the expression of a major stress protein system.
METHODS
Chinese hamster ovary (CHO) cells initially obtained from Los Alamos National Laboratory were maintained as monolayer cultures at 370C in Ham's F-10 medium (GIBCO) supplemented with 15% (vol/vol) newborn calf serum. The RIF-1 cell line was cultured in the a modification of minimal essential medium with 10% (vol/vol) fetal calf serum as described (20, 21) . In situ studies were performed by collecting cultured cells and then intradermally inoculating 3 x 105 cells into the right flank of C3H male mice. After 8-10 days, the tumor reached a diameter of8-10 mm. These tumors were excised and washed with Hanks' balanced salt solutions. The tumors were then separated into central and peripheral components [in a 3:7 (wt/wt) proportion]. The separated tissues were washed again, homogenized, and sonicated. The supernatant was collected after centrifugation and analyzed by NaDodSO4/PAGE and immunoblotting with a GRP76 antibody.
The antigen used in the preparation of antibodies directed against GRP76 was isolated by cutting the protein from two-dimensional gels (i.e., isoelectric focusing vs. NaDod-SO4/PAGE) of glucose deprived, GRP-induced CHO cells and was injected into a rabbit as described (22) . The protein spots on two-dimensional gels of control and GRP-induced CHO cells were transferred to nitrocellulose filters and then incubated at room temperature for 3 hr with antiserum (1:400 dilution) that was partially purified with 50% (wt/vol) ammonium sulfate. These immunoblots were incubated with goat anti-rabbit IgG conjugated to horseradish peroxidase (Boehringer Mannheim), as described (23) . The antiserum was found to be specific for GRP76, and its binding increased in quantity on the blots of the GRP-induced sample (unpublished data).
To achieve glucose depletion, 106 cells were seeded in a 100-mm dish and incubated for 12 hr to allow the cells to attach. At this time the medium was replaced with 5 ml of glucose-deficient F-10 medium (GIBCO) with 15% (vol/vol) newborn calf serum (containing serum levels of glucose). Cells were incubated in this low glucose medium, and the Sigma glucose calorimetric assay was used to monitor glucose levels. Glucose was entirely consumed by 20 hr, and GRPs were first seen at =z34 hr. For the calcium ionophore A23187 treatment, 106 cells were seeded and incubated for 36 hr, and A23187 was added to a final concentration of 10 ,uM.
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GRPs were induced within 2-4 hr. For 2-deoxyglucose treatment cells were again seeded as just described and incubated for 36 hr, at which time 2-deoxyglucose was added to a final concentration of 10 mM. GRPs were again induced within 2-4 hr. For anoxia experiments, cells were seeded as just described, except that glass culture dishes were used and that cells were incubated for 36 hr. At this time the medium was changed to 10 ml of medium containing 1 g/liter of glucose with an additional 200 Al/liter of 7.5% (wt/vol) sodium bicarbonate (to maintain physiologic pH during the exposure). Cells were then exposed to anoxia in a Brewerjar as described (5) . GRPs were induced within 4-8 hr. Release experiments were performed by removing inducing condition and then incubating cells in fresh medium for various times prior to labeling.
For gel electrophoresis, cultures were labeled for 1 hr with [35S]methionine (Amersham; 1000 Ci/mmol; 1 Ci = 37 GBq). Cells *ere washed two times with F-10 medium without serum at 40C, resuspended in Hanks' balanced salt solution with 1 mM tosyl-L-arginine methyl ester, 5 mM EDTA (Sigma), and 1 mM phenylmethylsulfonyl fluoride (Sigma) and sonicated at 40C. Protein determinations were made on lysate. NaDodSO4 sample buffer (24) was then added to the lysate. The protein synthesis assay employed discontinuous NaDodSO4/PAGE (12.95%) using the buffer system of Laemmli (24) . Equal amounts of protein as determined by the Bio-Rad protein determination assay were loaded in each lane. The autoradiograms shown in this paper used an 18-hr exposure of the dried gel to Kodak XAR-5 film. Designated molecular sizes are based on comparison with Bio-Rad high and low molecular weight standards.
At the same time that protein synthesis was assayed, parallel cultures were treated with the indicated concentrations of doxorubicin without extender (Sigma) for 1 hr. The drug was then removed, and the cells were washed three times, trypsinized, and plated for a single cell survival assay. All experiments and incubations were performed in the presence of a UV-blocking filter. In all studies cell densities of <6 x 106 cells per 100-mm dish were maintained, since at these densities no significant changes in doxorubicin resistance as a function of density were observed. A significant increase in doxorubicin resistance was observed at cell densities >8 x 106 cells per dish (10-20o survival at 10 ,ug/ml, 1-hr exposure) compared to sparsely seeded cells (0.3% survival). However, even in the confluent cultures GRP induction resulted in an additional 2-to 4-fold increase in resistance. In some conditions examined here (e.g., glucose deprivation), there was little alteration in cell cycle time.
Since release experiments require incubation times necessary for induction of GRPs, prior to the time that the release experiment may begin, the duration ofthe release experiment is limited by the cell density effect just described. Therefore, it was not possible in release experiments to follow the return of drug resistance to control levels. Radiolabeling and drug challenges were performed in full medium immediately after removal of the GRP-inducing condition. Addition of doxorubicin to GRP-induced cells prior to release yields a level of protection and a protein synthesis pattern that is not significantly different from that obtained immediately after release.
To determine doxorubicin levels in cells, a portion of the cell suspension used for determining single cell survival was collected in siliconized tubes and pelleted at 4°C (5 x 106 cells per pellet). Media were decanted, and cell pellets were frozen at -20°C until analyzed. For analysis, 100 /4 of water was added to each pellet followed by 300 ,l of 0.6 M HCO in ethanol. The tube was Vortex mixed and allowed to stand overnight at 40C. The extract was cleared of precipitate by centrifugation at 12,000 x g for 15 min, and a 100-1A sample was immediately injected onto an HPLC column. The HPLC system was equipped with a Waters ,uBondapak phenyl column (3.9 mm x 30 cm) preceded by a column inlet filter (0.5-gm pore) and a Waters Guard-PAK fitted with a CN cartridge. The mobile phase consisted of 27% (vol/vol) acetonitrile in 0.1 M ammonium formate buffer at pH 4.0. Experiments were performed isocratically at a flow rate of 2 ml/min. Detection and quantification of peaks have been described (25) .
RESULTS
We initially examined four methods of GRP induction in CHO cells to characterize the proteins induced and to determine the kinetics of their induction and repression. This information was then compared with single cell survival analysis of the development and disappearance of doxorubicin resistance under identical circumstances. In Fig. 1 the induction patterns for each of the four methods of GRP induction are presented. Glucose deprivation (lane 2), anoxia (lane 3 4) . A more weakly induced 170-kDa GRP is also seen in each of these cases, and the behavior of this GRP appears to parallel that of GRP97, being accompanied (or replaced) by a 150-kDa protein during sufficient stress (e.g., see lane 4). When visible, the 150-kDa protein reverts to the 170-kDa induced peptide upon release from the stress (e.g., see Fig. 2 B and C) and is also strongly labeled following incubation of glucose-deprived cells in [14C]glucose, as is GRP97 (data not shown). Anoxia is the strongest inducer of GRPs among the conditions defined and is seen to induce additional proteins, some of which are weakly induced by the other conditions. In the case of 2-deoxyglucose, A23187, and anoxia, the initial induction of GRPs occurs rapidly within the (C) Autoradiogram of pulse-chase study of the decay of GRPs in the first hours of treatment. In the case of glucose deprivation, however, induction of GRPs occurs 12-16 hr after the disappearance of detectable glucose from the culture medium. The pattern of GRP induction for 2-deoxyglucose is shown in Fig. 2A , and the induction by other methods is similar (data not shown).
When each of these conditions was removed by the addition ofglucose, reoxygenation, or removal of drug (either 2-deoxyglucose or A23187), the synthesis of the proteins just described was repressed, ultimately returning to control levels of synthesis after various intervals. The same time that this repression occurred, an induction of the major 70-and 89-kDa heat shock proteins was observed in every case, strengthening our earlier suggestion that the release from a GRP-inducing state elicits a heat shock response (5, 12) . Repression of GRPs (and heat shock protein induction) was seen to occur most rapidly after release from glucose deprivation (a few hours) and occurred somewhat more slowly after release from the other conditions. Fig. 2B shows the pattern of GRP repression after removal of 2-deoxyglucose. Fig. 2C shows a pulse-chase study of the decay of the induced proteins in the cell which indicates that GRPs remain well above control levels up to 24 hr following release from 2-deoxyglucose (i.e., during the period when drug resistance disappears), and enhanced levels are detectable for longer periods. Fig. 3 compares resistance of cells to the drug doxorubicin that results from treatments with anoxia, glucose deprivation, 2-deoxyglucose, and A23187. In each case, the same exposure conditions as those used to obtain the data presented in Fig. 1 were employed. It is seen from this data that one to two orders of magnitude of drug resistance occur in the GRP-induced cells at drug concentrations >3 ,ug/ml. In addition, anoxia, the strongest inducer of GRPs (using the protocols defined here), is also the strongest inducer of resistance. A23187 was consistently the weakest inducer of resistance. Fig. 4 shows the induction kinetics of this resistance that occur during exposure to each of these conditions, and Fig. 5 shows the kinetics of repression that occur following removal of each of these conditions. These kinetic studies used doxorubicin at 10 gg/ml applied for 1 hr. During each of the GRP-inducing treatments considered here, the induction of drug resistance is seen to occur rapidly after application of the GRP-inducing stress. A23187, 2-deoxyglucose, and anoxia lead to a rapid induction in GRPs, and a strong correlation between GRP synthesis and drug resistance is seen in these cases. Glucose deprivation, on the other hand, yields somewhat different data. While this condition clearly produces a resistant state, the initial onset of resistance occurs rapidly as glucose is depleted and precedes the detectable induction of GRPs. The repression of resistance following removal of each condition correlates with the repression of GRP induction and not with the decay of the induced GRPs in the cells as can be seen by comparing Fig.  2 B and C with Fig. 5 . Additionally, repression of drug resistance also correlates closely with the induction of heat shock proteins in each of these cases, since heat shock protein induction and GRP repression are temporally related.
The doxorubicin content of both unstressed and prestressed cells (employing the same GRP-inducing conditions used to determine the GRP induction data in Fig. 1 and the survival data in Fig. 3 ) was examined in several experiments following exposure of the cells to the drug at 10 Ag/ml for 1 cell. Cells were treated with 10 mM 2-deoxyglucose for 12 hr and then radiolabeled for 1 hr. Cells were then postincubated in fresh medium for the hours indicated above the lanes. Molecular size standards are as in Fig. 1 tion resulting from exposure to any of these conditions (data not shown). Finally, GRPs have been studied in a variety of cell lines and tissues and, as with the major heat shock proteins, the major GRPs appear to occur widely (2) . However, the presence and abundance of GRPs in animal tumors have not been examined. To begin to investigate whether the observations described above may be applicable to tumors in situ, we have used the RIF in vitro/in vivo tumor system (20, 21) . RIF cells, grown in vitro, also exhibit an induction of GRPs when exposed to each of the conditions defined above (data not shown). 
DISCUSSION
We have shown in this study that the application of GRPinducing environments results in a cellular state in which the induction of resistance to the drug doxorubicin is also observed. The fact that four separate procedures for GRP induction led to doxorubicin resistance strongly suggests that some aspect of the GRP-induced state is related to this resistance phenomenon. However, this protective phenomenon differs from the relationship between the heat-resistant phenomenon of thermotolerance and heat shock proteins.
Thermotolerance decays slowly in the cell, in a manner consistent with the decay of heat shock proteins (26, 27 
